In addition, fenofibrate reverts arthritis-induced decrease in soleus mass and this effect is associated with decreased expression of Murf1 and myostatin, as well as upregulation of MyoD and myogenin expressions. The gene discussed is MSTN; the disease is arthritic joint disease.